CCS Medical Revenue and Competitors

Claim your profile

Dallas, TX USA



Total Funding

Estimated Revenue & Valuation

  • CCS Medical's estimated annual revenue is currently $267.6M per year.(i)
  • CCS Medical's estimated revenue per employee is $251,000

Employee Data

  • CCS Medical has 1066 Employees.(i)
  • CCS Medical grew their employee count by 5% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

CCS Medical Holdings, Inc. (CCS Medical) is medical supply management company delivering products and value-added services to individuals living with select chronic medical conditions, including diabetes, urological and ostomy-related disorders, chronic wounds, incontinence, respiratory conditions and other illnesses. CCS Medical operates its business in two segments. The direct-to-consumer segment provides for direct mail of its products to patients suffering from chronic diseases. Its business-to-business segment provides diabetes testing supplies and related products on a wholesale basis to providers and distributors. On December 11, 2006, the Company acquired, through its wholly owned subsidiary, Sanvita, Inc., inventory and certain other assets and assumed certain liabilities from the blood glucose monitoring division of Becton, Dickinson and Company.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





CCS Medical News

2022-04-17 - Risk perceptions and health care use in the era of the COVID-19 pandemic in adults treated for childhood cancer

Forgoing medical appointments was more common among CCS who reported a deterioration in their financial situation in 2020 and those who felt...

2022-04-06 - Effects of bedside team-based learning on pediatric clinical ...

Thirty medical students in pediatric clinical practice were randomly ... The CCS scores in the intervention group were significantly higher...

2022-04-06 - Canadian Cancer Society (CCS) and Creative Destruction Lab (CDL) partner to launch a unique program for seed-stage companies commercializing cancer research results

This could include new ways to detect cancer earlier, screening methods tailored to communities, and advancements in precision medicine.

2011-12-06 - Tengion gets new CEO as it pursues strategic partnership talks

Last month, in its third-quarter earnings, Tengion revealed a restructuring plan that involved cutting 30 from its workforce and centralizing its R&D operations in its leased facility in Winston-Salem, North Carolina. Scheer said: “As we continue to pursue strategic partnership and financing di ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding